Devro PLC Trading Update (1859T)

TIDMDVO

RNS Number : 1859T

Devro PLC

23 November 2021

Devro plc

Trading Update

Devro plc ("Devro" or the "Company"), one of the world's leading manufacturers of collagen products for the food industry, issues the following trading update for the period 30 June to 31 October 2021.

Current trading

Trading in the period has been encouraging, with constant currency revenue growth above that seen in H1 2021, reflecting the successful execution of our growth strategy delivering volume growth, higher prices and improved mix. Mature markets were strong with continued growth in North America and improved sequential trends in Continental Europe and UK & Ireland. Emerging market growth was particularly strong in Latin America and Middle East and Africa. While the Group is experiencing inflationary pressure this is being mitigated through pricing action and tight cost management.

Financial position and Foreign exchange

Cash generation continues to be strong; as expected the Group is on track for covenant net debt to EBITDA of c.1.5x at year-end. As previously highlighted the Company is seeing the impact of strengthening foreign exchange headwinds with the adverse year on year impact expected to be c.GBP3 million on full year operating profit.

Outlook

The Board's expectations for the full year 2021 remain unchanged. As we look forward to 2022 we are positive about the outlook but remain alert to global supply chain challenges, inflation and further foreign exchange headwinds.

ENDS

Contacts :

Devro plc

 
 Rutger Helbing   Chief Executive Officer   Tel: [phone] 
 Rohan Cummings   Chief Financial Officer   Tel: [phone] 
 

FTI Consulting

 
 Richard Mountain     Tel: [phone] 
 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

TSTFELFWEEFSEIF

(END) Dow Jones Newswires

November 23, 2021 02:00 ET (07:00 GMT)